CEO James Mackin于2月24日出售了497K多美元, CEO James Mackin sold over $497K in Artivion shares on Feb. 24, amid strong earnings and insider selling.

2026年2月24日,Artivion首席执行官詹姆斯·麦金以每股35.69美元的价格出售了13936股股票,总计约为497376美元,减少了他的股份1.79%. On February 24, 2026, Artivion CEO James Mackin sold 13,936 shares at $35.69 each, totaling about $497,376, reducing his stake by 1.79%. 其他内部人士,包括CAO和SVP Marshall Stanton也在2月23日至24日出售股票。 Other insiders, including CAO and SVP Marshall Stanton, also sold shares on February 23–24. 2月12日,该公司报告Q4收入丰厚,有17美元EPS和1.183亿美元收入,比上一年增加19.2%。 The company reported strong Q4 earnings on February 12, with $0.17 EPS and $118.3 million in revenue, up 19.2% year-over-year. 据悉,Artivion的市值为171亿美元,分析师认为,其目标价为48.97美元. Artivion, formerly CryoLife, has a market cap of $1.71 billion and a “Moderate Buy” analyst consensus with a $48.97 target. 2月25日股票交易额为35.66美元,低于平均数量。 The stock traded at $35.66 on February 25, below average volume.